Medy-Tox Inc Working Capital to Net Assets Ratio
Medy-Tox Inc working capital to net assets ratio. Medy-Tox Inc (086900) has a Working Capital to Net Assets ratio of 16.1% as of September 2025. Working capital of ₩75.11 Billion (current assets of ₩170.70 Billion minus current liabilities of ₩95.59 Billion) is measured against net assets of ₩467.65 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base. Check Medy-Tox Inc tangible equity quality to evaluate the tangible quality of the company's equity base.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Working Capital to Net Assets Ratio of Medy-Tox Inc (2014–2024)
Working capital to net assets ratio of Medy-Tox Inc from 2014 to 2024. This chart shows how Medy-Tox Inc's Working Capital to Net Assets ratio has evolved across 11 annual periods from 2014 to 2024. As of September 2025, the ratio stands at 16.1%, reflecting working capital of ₩75.11 Billion against net assets of ₩467.65 Billion KRW. See Medy-Tox Inc defensive interval ratio to measure how many days the company can operate on defensive assets alone.
Medy-Tox Inc Working Capital to Net Assets Ratio by Year (2014–2024)
Medy-Tox Inc working capital to net assets ratio by year from 2014 to 2024. The table below presents the year-by-year Working Capital to Net Assets ratio for Medy-Tox Inc from 2014 to 2024, covering 11 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see how large is Medy-Tox Inc's balance sheet.
| Year | WC/NA Ratio | Working Capital (KRW) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 14.7% | ₩69.02 Billion | ₩470.78 Billion | ₩186.57 Billion | ₩117.55 Billion | ▲ +6.3 pp |
| 2023 | 8.4% | ₩39.68 Billion | ₩474.48 Billion | ₩166.23 Billion | ₩126.56 Billion | ▲ +8.4 pp |
| 2022 | 0.0% | ₩-128.34 Million | ₩428.04 Billion | ₩135.13 Billion | ₩135.26 Billion | ▼ -13.3 pp |
| 2021 | 13.3% | ₩53.01 Billion | ₩399.48 Billion | ₩160.96 Billion | ₩107.95 Billion | ▲ +4.5 pp |
| 2020 | 8.7% | ₩21.12 Billion | ₩241.40 Billion | ₩138.71 Billion | ₩117.59 Billion | ▲ +15.0 pp |
| 2019 | -6.3% | ₩-16.32 Billion | ₩259.15 Billion | ₩120.03 Billion | ₩136.35 Billion | ▼ -8.5 pp |
| 2018 | 2.2% | ₩5.62 Billion | ₩252.59 Billion | ₩116.43 Billion | ₩110.82 Billion | ▲ +20.1 pp |
| 2017 | -17.9% | ₩-34.23 Billion | ₩191.65 Billion | ₩103.15 Billion | ₩137.39 Billion | ▼ -12.5 pp |
| 2016 | -5.4% | ₩-7.96 Billion | ₩147.68 Billion | ₩68.60 Billion | ₩76.56 Billion | ▼ -54.7 pp |
| 2015 | 49.3% | ₩55.95 Billion | ₩113.48 Billion | ₩103.48 Billion | ₩47.53 Billion | ▼ -34.4 pp |
| 2014 | 83.7% | ₩68.25 Billion | ₩81.59 Billion | ₩103.25 Billion | ₩35.00 Billion | — |